Maria Rincon

ORCID: 0000-0002-9909-8567
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Lipids, and Metabolism
  • Plant-Derived Bioactive Compounds
  • Tannin, Tannase and Anticancer Activities
  • Epigenetics and DNA Methylation
  • Cancer survivorship and care
  • Global Cancer Incidence and Screening
  • Prostate Cancer Treatment and Research
  • Palliative Care and End-of-Life Issues
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Patient Satisfaction in Healthcare
  • Tea Polyphenols and Effects
  • Biological Activity of Diterpenoids and Biflavonoids
  • Health Literacy and Information Accessibility
  • Thyroid Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Food Safety and Hygiene
  • Cancer-related gene regulation
  • Genetics, Bioinformatics, and Biomedical Research
  • Head and Neck Cancer Studies
  • Liver Disease Diagnosis and Treatment
  • Medical research and treatments
  • Inflammatory mediators and NSAID effects
  • Childhood Cancer Survivors' Quality of Life
  • Renal cell carcinoma treatment

University of Cartagena
2023-2024

University of New Mexico
2023

Hospital Pablo Tobon Uribe
2023

Temple University
2019-2023

National Cancer Institute
2017-2020

Moffitt Cancer Center
2010-2016

Washington University in St. Louis
2014

Catholic University of Korea
2014

Sanford Burnham Prebys Medical Discovery Institute
2014

University of South Florida
2012

Internet-based peer support groups (ISGs) represent an innovative, scalable approach to addressing information and needs of cancer survivors. However, this innovation may not benefit survivors equally due population variance in digital literacy. This study examined how literacy influences level engagement psychological benefits from participating ISGs for breast (N = 183).Secondary analysis data a randomised trial that included behavioural measures engagement, subjective ratings distress...

10.1111/ecc.13134 article EN European Journal of Cancer Care 2019-07-01

Prostate cancer treatment is often accompanied by untoward side effects. Therefore, chemoprevention to reduce the risk and inhibit progression of prostate may be an effective approach reducing disease burden. We investigated safety efficacy Polyphenon E, a green tea extract, in transgenic adenocarcinoma mouse (TRAMP) mice. A total 119 male TRAMP C57BL/6J mice were treated orally with one 3 doses E (200, 500, 1,000 mg/kg/day) drinking water ad libitum replicating human achievable doses....

10.1158/1940-6207.capr-13-0427-t article EN Cancer Prevention Research 2014-02-06

Abstract Background: Non-White cancer survivors often report poorer health compared with Non-Hispanic Whites. Whether those disparities are changing over time is unknown. We examined changes in health-related quality of life (HRQOL) by race/ethnicity from 1998 to 2012 among older adults and without cancer. Methods: Data Medicare Advantage beneficiaries were obtained the linkage between Health Outcomes Survey Surveillance, Epidemiology, End Results registry data (SEER-MHOS). HRQOL was...

10.1158/1055-9965.epi-19-0819 article EN Cancer Epidemiology Biomarkers & Prevention 2020-03-13

During quit attempts, smokers must overcome smoking urges triggered by environmental cues and nicotine withdrawal symptoms. This study investigates the psychometric properties of 12-item Tobacco Urge Management Scale (TUMS), a new measure urge management behaviors. We analyzed secondary data (n = 327) from behavioral cessation intervention trial, Kids Safe Smokefree (KiSS). Confirmatory factor analysis TUMS indicated that one-factor model correlated two-factor had similar fit indices,...

10.3390/ijerph20085453 article EN International Journal of Environmental Research and Public Health 2023-04-10

The simultaneous occurrence of more than two types neoplasms is rare due to their significant phenotypic differences. Thyroid carcinoma regularly associated with genetic alterations and endocrine syndromes. However, the etiology forms papillary thyroid (PTC)/medullary (MTC) still not fully understood. We present case a 60-year-old male no history disease who presented dysphonia. Left vocal cord paralysis cervical tumor lesion were observed. A mixed medullary/papillary was diagnosed. Surgical...

10.7759/cureus.71581 article EN Cureus 2024-10-16

<sec> <title>BACKGROUND</title> Broadband Internet plays an increasingly important role in supporting healthcare delivery and enhancing access to care health information. Although broadband has the potential alleviate inequities healthcare, digital divide negatively impacts cancer across continuum, from prevention information, early diagnostics treatment, survival outcomes. While subscription services been previously assessed, satisfaction with individual at-home internet connection is a...

10.2196/preprints.69606 preprint EN cc-by 2024-12-03

Abstract Introduction: Prostate cancer is the most common and second leading cause of death in American men. Among patients who have a radical prostatectomy, ∼30% will disease recurrence. Currently, level prostate specific antigen (PSA), clinical stage (TNM) tumor grade (Gleason score) are used to estimate prognosis inform treatment modalities. Although these extremely useful, additional biomarkers needed better predict outcome. Angiogenesis has been associated with Gleason score, stage,...

10.1158/1538-7445.am2012-2615 article EN Cancer Research 2012-04-01

4732 Background: Prostate cancer, a tumor dependent upon angiogenesis, frequently expresses vascular endothelial growth factor (VEGF), cyclo-oxygenase 2 (COX2) as well interleukin 6 (IL-6) receptors. Thalidomide (T) manifests its anti-angiogenic activity via both basic fibroblast (bFGF) and VEGF pathways can also down regulate the production of IL-6. has been shown to effect PSA responses in AIPC. COX2 inhibitors ablate bFGF mediated angiogenesis cause apoptosis prostate cancer cell lines....

10.1200/jco.2005.23.16_suppl.4732 article EN Journal of Clinical Oncology 2005-06-01

&lt;div&gt;Abstract&lt;p&gt;Prostate cancer treatment is often accompanied by untoward side effects. Therefore, chemoprevention to reduce the risk and inhibit progression of prostate may be an effective approach reducing disease burden. We investigated safety efficacy Polyphenon E, a green tea extract, in transgenic adenocarcinoma mouse (TRAMP) mice. A total 119 male TRAMP C57BL/6J mice were treated orally with one 3 doses E (200, 500, 1,000 mg/kg/day) drinking water &lt;i&gt;ad...

10.1158/1940-6207.c.6544595 preprint EN 2023-04-03

&lt;p&gt;PDF file - 65K, Supplemental Figure 1. Body and prostate gland weights of C57BL/6J TRAMP mice: A. weight change C57BL/6J. B. Prostate C. TRAMP. D. 2. Mean distribution-adjusted lesion grade different lobes (anterior, dorsal, lateral ventral) the in control mice treated with low, medium high doses Polyphenon E.&lt;/p&gt;

10.1158/1940-6207.22525139 preprint EN cc-by 2023-04-03

&lt;p&gt;PDF file - 65K, Supplemental Figure 1. Body and prostate gland weights of C57BL/6J TRAMP mice: A. weight change C57BL/6J. B. Prostate C. TRAMP. D. 2. Mean distribution-adjusted lesion grade different lobes (anterior, dorsal, lateral ventral) the in control mice treated with low, medium high doses Polyphenon E.&lt;/p&gt;

10.1158/1940-6207.22525139.v1 preprint EN cc-by 2023-04-03

&lt;div&gt;Abstract&lt;p&gt;Prostate cancer treatment is often accompanied by untoward side effects. Therefore, chemoprevention to reduce the risk and inhibit progression of prostate may be an effective approach reducing disease burden. We investigated safety efficacy Polyphenon E, a green tea extract, in transgenic adenocarcinoma mouse (TRAMP) mice. A total 119 male TRAMP C57BL/6J mice were treated orally with one 3 doses E (200, 500, 1,000 mg/kg/day) drinking water &lt;i&gt;ad...

10.1158/1940-6207.c.6544595.v1 preprint EN 2023-04-03

Abstract Prostate cancer is the most common in men, comprising approximately one-third of all male-specific cancers. SLC5A8 a sodium-coupled transporter for short-chain fatty acids which are known to induce apoptosis by histone deacetylase inhibition. Previous studies suggest that may function as tumor suppressor gene whose silencing epigenetic changes contribute carcinogenesis. For this reason, we investigated role expression and single nucleotide polymorphisms (SNPs) prostate risk...

10.1158/1538-7445.am10-2851 article EN Cancer Research 2010-04-01

Abstract Introduction: The lack of underrepresented individuals in the vast fields scientific cancer research underlines need for effective training programs to encourage aspiring trainees. There is a dire expand number scientists decrease mortality rates and incidences minority populations. Training initiatives demand creativity, flexibility, commitment sincere desire produce change system. Description: Project LINK (Leaders New Knowledge) solution this problem. Its primary goal create...

10.1158/1055-9965.disp-10-b33 article EN Cancer Epidemiology Biomarkers & Prevention 2010-10-01

238 Background: Care experience ratings are recognized as measures of quality. We introduce a new resource, SEER-CAHPS, linking cancer registry data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) program with Medicare claims Consumer Assessment Healthcare Providers Systems (CAHPS) survey. Methods: The SEER-CAHPS resource includes 1973-2011 (diagnosis, incidence, mortality, sociodemographic data), CAHPS survey 1998-2013 (sociodemographic, health status,...

10.1200/jco.2017.35.8_suppl.238 article EN Journal of Clinical Oncology 2017-03-10

6595 Background: Care experience ratings are recognized as measures of healthcare quality. Here we introduce a new, public data resource, SEER-CAHPS, which links cancer registry from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) program with Medicare claims Consumer Assessment Healthcare Providers Systems (MCAHPS) survey. Methods: The SEER-CAHPS resource includes 1973-2011 (diagnosis, incidence, mortality, sociodemographic data), CAHPS survey 1998-2013...

10.1200/jco.2017.35.15_suppl.6595 article EN Journal of Clinical Oncology 2017-05-20
Coming Soon ...